OncoMed is having a no good, very bad week

Four pieces of bad news have buffeted the biotech’s stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.